A new sesquiterpene, albican-11,14-diol (1), and seven known compounds, including sterigmatocystin (2), 3-hydroxy-5-(hydroxymethyl)-4-(4'hydroxyphenoxy) pyrrolidin-2-one (3), (1H-indol-3-yl) oxoacetamide (4), indole-3-carboxylic acid (5), indole-3-acetic acid (6), indole-3-carboxaldehyde (7), and volemolide (8), were isolated from the cultures of Aspergillus versicolor, an endophytic fungus isolated from the marine green alga Codium fragile. The structure of 1 was elucidated by 1D, 2D NMR and mass spectroscopic techniques. The bioassay results showed that 1 possessed potent activity against brine shrimp, Escherichia coli, and Staphyloccocus aureus.
Aspergillus versicolor is a source of fungal toxins, bioactive alkaloids, polyketides, cyclopeptides, and terpenes [1] [2] [3] . During our search for bioactive metabolites from marine organisms, an alga-endophytic A. versicolor strain was isolated from the marine green alga Codium fragile and a new sesquiterpene, albican-11,14diol (1), and seven known compounds, including sterigmatocystin (2) [3] , 3-hydroxy-5-(hydroxymethyl)-4-(4'-hydroxyphenoxy) pyrrolidin-2-one (3) [4] , (1H-indol-3-yl) oxoacetamide (4) [5] , indole-3-carboxylic acid (5) [6] , indole-3-acetic acid (6) [7] , indole-3carboxaldehyde (7) [8] , and volemolide (8) [8] were isolated and characterized ( Figure 1A ). Details of their isolation, structure elucidation, and, for 1, biological activity are presented here.
Compound 1 was obtained as a colorless oil. The IR spectrum showed an absorption band at 3386 cm -1 , which indicated the presence of hydroxyl groups in the molecule. The molecular formula was deduced to be C 15 H 26 O 2 by HREIMS (m/z 238.1925, [M] + calcd for 238.1933). The 1 H NMR spectrum (Table 1) along with the HSQC experiment exhibited two methyl singlets, one doublet and three double doublets assigned to two oxygenated methylenes, and a pair of doublets characteristic of an exocyclic methylene unit. The 13 C NMR spectrum (Table 1) had 15 lines consisting of two methyls, eight methylenes, two methines, and three quaternary carbons by the DEPT experiment. The 1 H-1 H COSY correlations ( Figure 1B ) indicated the presence of structural unit -CH 2 -CH 2 -CH 2 -(C-1 to C-3), -CH-CH 2 -CH 2 -(C-5 to C-7), and -CH-CH 2 OH (C-9 to C-11). The connectivity of the above sequences at quaternary C-4, C-8, and C-10 was established by the HMBC correlations from H-11 to C-8, from H-12 to C-7 and C-9, from H-13 to C-1, C-5, C-9, and C-10, from H-14 to C-3, C-4, and C-15, and from H-15 to C-3, C-4, C-5, and C-14 ( Figure 1b ). The planar structure of 1 being thus established, the relative configuration was determined from the NOESY spectrum which indicated that C-11, C-13, and C-14 were on the same face of the molecule based on the correlations between H-13, H-11 and H-14. Additionally, H-5 and C-15 were deduced to be cofacial according to the NOESY correlation between H-5 and H-15. The above data indicates that 1 is albican-11,14-diol which closely resembles albican-11,15-diol, but for their differing 13 C NMR at C-5, C-14, and C-15 [9] . [6] , (1H-indol-3-yl) methanamine (6) [7] , indole-3-carboxaldehyde (7) [8] , and volemolide (8) [8] , were identified based on NMR comparison with literature values. Compound 1 was evaluated for bioactivities against bacteria and brine shrimp [1b,10]. Antibacterial activity was assessed by a disk diffusion assay against Escherichia coli and Staphylococcus aureus at a concentration of 30 μg/disk, to give inhibitory diameters of 7 and 10.3 mm, respectively. Additionally, 1 exhibited toxicity against brine shrimp (Artemia salina) with an LC 50 value of 35.0 μg/mL.
Experimental
General experimental procedures: NMR, Bruker Avance III 500 NMR; MS, Autospec Premier P776 and LCQ Fleet mass spectrometer; IR, JASCO FT/IR-4100; Optical rotation, JASCO P-1020 polarimeter; HPLC separation was carried out on an Elite HPLC system (P270 pump, UV230+ detector, Dalian Elite Analytical Instruments Co., Ltd, Dalian, China) using an Eclipse XDB-C18 (5 μm, 9.4×250 mm) columm. CC, silica gel (200-300 mesh, Qingdao, China) and Sephadex LH-20 (Pharmacia). TLC was carried out with precoated silica gel plates (GF-254). All solvents were of analytical grade.
Microorganism and fermentation:
The endophytic fungal strain Aspergillus versicolor dl29 was isolated from the fresh tissue of surface-sterilized marine green alga Codium fragile that was collected off the coast of Dalian, China. The fungus was identified based on morphological and molecular taxonomic methods and was preserved at the China Center for Type Culture Collection with access number CCTCC M 2011421. The initial cultures were maintained on the potato dextrose agar (PDA) plate. Pieces of mycelia were cut into small segments and aseptically inoculated into 50 Erlenmeyer flasks (1L), each containing 300 mL potato dextrose broth (PDB) culture media. Static fermentation was performed at room temperature for 30 days.
Extraction and isolation:
The whole cultures (300 mL × 50 flasks) were filtered through cheesecloth to separate mycelia from broth. The broth was extracted with EtOAc to give an evaporated extract (9.2 g). The dried mycelia were homogenized and extracted with a mixture of CHCl 3 and MeOH (1:1, v/v), then the evaporated extract was partitioned between EtOAc and H 2 O to yield an EtOAc-soluble extract (20.2 g). These two parts were combined for further separation based on their identical TLC profiles. The total EtOAcsoluble fraction (29.4 g) was subjected to step-gradient silica gel column chromatography (CC) with a solvent system consisting of 0-100% petroleum ether (PE)-EtOAc to afford 14 fractions (Frs. 1-14) based on TLC analysis. Fr. 8 eluted with PE/EtOAc (5:1) and was further purified by CC on silica gel (PE/EtOAc, 4:1) to provide two subfractions (Fr. 8.1 and 8.2). Fr. 8.1 was further purified by CC on Sephadex LH-20 (CHCl 3 /MeOH, 1:1) to give two subfractions (Fr. 8.1.1, 8.1.2) . Fr. 8.1.1 was further purified by preparative TLC (CHCl 3 /acetone, 4:1) to yield 2 (43.5mg). Fr. 8.1.2 was further purified by preparative HPLC (MeOH/H 2 O, 85:15) to give 8 (3.0 mg). Fr. 9 eluted with PE/EtOAc (2:1) and was further purified by CC on Sephadex LH-20 (CHCl 3 /MeOH, 1:1), preparative HPLC (MeOH/H 2 O, 85:15), and preparative TLC (PE/EtOAc, 1:1) to yield 1 (3.8 mg). Fr.10 eluted with PE/EtOAc (2:1) and was further purified by CC on Sephadex LH-20 (CHCl 3 /MeOH, 1:1), silica gel (PE/EtOAc, 2:1), and preparative TLC (CHCl 3 /Acetone, 3:1) to afford 7 (8.1 mg). Fr.11 eluted with PE/EtOAc (2:1) and was further purified by CC on Sephadex LH-20 (CHCl 3 /MeOH, 1:1) to give two subfractions (Fr.11.1 and 11.2). Fr.11.1 was further purified by CC on silica gel (PE/EtOAc, 2:1) and preparative TLC (PE/Acetone, 1:2) to give 5 (6.3 mg) and 6 (5.2 mg). Fr.12 eluted with EtOAc and was further purified by CC on silica gel (PE/EtOAc, 2:1) to provide two subfractions (Fr.12.1-12.2). Fr.12.1 was further purified by CC on Sephadex LH-20 (CHCl 3 /MeOH, 1:1) and preparative TLC (PE/EtOAc, 1:4, 2%HAc) to yield 3 (19.0 mg). Fr.12.2 was further purified by CC on Sephadex LH-20 (CHCl 3 /MeOH, 1:1) and preparative TLC (CHCl 3 /EtOAc, 1:3) to give 4 (4.8 mg). Supplementary data: 1 H, 13 C, DEPT, HSQC, HMBC, 1 H-1 H COSY, NOESY, HREIMS, and IR spectra for compound 1. 1 H, 13 C, DEPT, and mass spectra for compounds 2-8.
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